Prodia Diagnostic Line Tbk vs Kedoya Adyaraya Tbk. — how do they compare? Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume), while Kedoya Adyaraya Tbk. trades at Rp930 (market cap 883.19B, 10K 24h volume). The key difference: Kedoya Adyaraya Tbk. is the larger of the two by market cap, and Prodia Diagnostic Line Tbk is more actively traded (18.86M versus 10K). Which is the better fit depends on your goals.
| PRDL | RSGK | |
|---|---|---|
Market Cap | 470.58B | 883.19B |
Volume | 18.86M | 10K |
Lot | 188.57K | 100 |
Turnover | 4.97B | 9.39M |
Average Price | 263.63 | 939.05 |
Value | 4.97B | 9.39M |
Indicative Equilibrium Price | 264 | — |
Indicative Equilibrium Volume | 3.64K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →PT Kedoya Adyaraya Tbk (the Company) was established on June 11, 1990 based on Notarial Deed No. 104 of Darsono Purnomosidi, S.H., Notary in Jakarta. The Company started its commercial operations in 2011. PT Medikatama Sejahtera is the ultimate parent Company of the Company and its Subsidiaries.
Read more on RSGK →